Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TerveystaloTTALF -30.89%69 EV-to-EBIT is 14.43 as of Sep. 02, 2026, which is 35% below its 10-year median of 22.29. GuruFocus rates TTALF with a GF Score™ of 69/100 and a GF Value™ of $10.12. The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Terveystalo ranks better than 54.3% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Terveystalo's Enterprise Value for the quarter that ended in Jun. 2026 was $1,780 Mil.
Terveystalo's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $124 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terveystalo EV-to-EBIT Related Terms
Terveystalo EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Terveystalo's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Terveystalo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terveystalo EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Terveystalo's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Terveystalo's EV-to-EBIT falls into.
Terveystalo's current Enterprise Value is $1,792 Mil.
Terveystalo's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $124 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terveystalo (TTALF) has a EV-to-EBIT of 14.43 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Terveystalo and its competitors. This is 35% below median its historical median of 22.29. According to the industry distribution chart, Terveystalo ranks #218 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Terveystalo's EV-to-EBIT too high?
Terveystalo's current EV-to-EBIT of 14.43 is 35% below median its 10-year median of 22.29. The Healthcare Providers & Services industry median EV-to-EBIT is 15.49. Terveystalo's value of 14.43 is 6.8% below this industry median. Based on the distribution chart, Terveystalo ranks #218 out of 477 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Terveystalo has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Terveystalo's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Terveystalo ranks #218 out of 477 companies for EV-to-EBIT. This puts Terveystalo in the upper half of its industry. The industry median EV-to-EBIT is 15.49. Terveystalo's value of 14.43 is 6.8% below this benchmark. While the company's 10-year median is 22.29 vs. the industry median of 15.49, Terveystalo has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.49, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terveystalo's current EV-to-EBIT of 14.43 is 6.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Terveystalo and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terveystalo's current EV-to-EBIT is 14.43, which is 35% below median its own 10-year median of 22.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terveystalo stock overvalued right now?
Terveystalo (TTALF) has a current EV-to-EBIT of 14.43. The stock's GF Value™ is $10.12, compared to a current price of $8.95 — trading 11.6% below its estimated fair value. The current EV-to-EBIT is 14.43, which is 35% below median its 10-year median of 22.29 and 6.8% below the Healthcare Providers & Services industry median of 15.49. Terveystalo's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Terveystalo (TTALF), the current EV-to-EBIT is 14.43 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terveystalo (TTALF) Overvalued in 2026?
Based on GuruFocus' analysis, Terveystalo stock appears to be undervalued.
The current stock price of $8.95 is trading 11.6% below its estimated GF Value™ of $10.12.
Key valuation signals for TTALF:
EV-to-EBIT: 14.43 (35% below median its 10-year median of 22.29)
GF Value™: $10.12 vs. price of $8.95 (11.6% below fair value)
Industry Position: 6.8% below the Healthcare Providers & Services median (#218 of 477)
No single metric tells the full story. See the TTALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. The healthcare service offering of the company includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
69GF Score
Get the complete analysis for TTALF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TTALF has been successfully added to your 
